Actinium Pharmaceuticals Inc.

08/01/2024 | Press release | Distributed by Public on 08/01/2024 06:00

Actinium Expands Patent Coverage Over Iomab ACT, its Next Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell Based Therapies for Non Malignant[...]